TransMedics (TMDX) Cash from Operations (2018 - 2026)

TransMedics has reported Cash from Operations for 9 years, with the latest figure at $17.3 million in Q2 2026.

• On a quarterly basis, Cash from Operations fell 81.11% year-over-year to $17.3 million in Q2 2026; TTM through Jun 2026 was $145.9 million, a 26.59% increase from a year earlier, with the FY2025 full-year figure at $192.8 million, up 295.14% from the prior year.
• Cash from Operations was $17.3 million for Q2 2026 at TransMedics, down from $24.5 million in the prior quarter.
• The five-year high for Cash from Operations was $91.6 million in Q2 2025, with the low at -$18.4 million in Q1 2022.
• Average Cash from Operations over 5 years is $12.5 million, with a median of $2.0 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Cash from Operations tumbled 151.11% in 2022, then surged 959.3% in 2026.
• Over 5 years, Cash from Operations stood at -$4.0 million in 2022, then jumped by 305.8% to $8.3 million in 2023, then jumped by 136.79% to $19.7 million in 2024, then surged by 75.52% to $34.5 million in 2025, then sank by 49.85% to $17.3 million in 2026.
• The last three Cash from Operations figures came in at $17.3 million (Q2 2026), $24.5 million (Q1 2026), and $34.5 million (Q4 2025), per Business Quant data.